OHLCX Market Research
Delayed

BMY

Bristol Myers Squibb is a global biopharmaceutical company that discovers, develops, and delivers innovative medicines for serious diseases.

+0.66 (+1.13%) Nov 20, 2026 19:37 ET Delayed
Open
58.61
High
59.81
Low
58.34
Prev close
58.34
Volume
12M
Avg vol 10
10M

Today · Market closed · opens Mon 9:30 AM

Price

BMY chart

Updating chart…

Scroll or pinch to zoom, drag to pan, or use the buttons on the chart. About the price history

Signals

Technical analysis

Daily bars · last bar Nov 20, 2026 · close 59.00

Strong sellNeutralStrong buy
Neutral
score 0.00 · 18 signalling
6Buy
6Neutral
6Sell

No clear lean. 6 buy, 6 neutral and 6 sell across 18 signals. Stochastic, Stoch RSI, Williams %R and CCI sit in oversold territory. Trend strength is weak (ADX 15).

How to read this →

Trend

MACD 12, 26, 9
Below signal line and zero
MACD −0.42 · Signal 0.04 · Hist −0.45
Sell
ADX 14
Weak trend, −DI ahead
ADX 14.54 · +DI 22.30 · −DI 30.04
Neutral
Parabolic SAR 0.02, 0.2
Above price, 5.76 over the close
64.76
Sell
Ichimoku 9, 26, 52
Price below cloud, conversion below base
Conv 61.41 · Base 61.71 · A 59.96 · B 62.39
Sell

Momentum

RSI 14
Mid-range, no extreme
40.34
Neutral
Stoch 14, 3
Oversold, %K just crossed over %D
%K 14.62 · %D 7.32
Buy
Stoch RSI 14, 14, 3, 3
Oversold, %K still below %D
%K 4.62 · %D 7.24
Neutral
Williams %R 14
Oversold zone, still rising
−85.38
Buy
CCI 14
Below −100, turning up
−149.39
Buy
MFI 14
Above midpoint, not overbought
59.84
Neutral
ROC 12
Price down 8.09% over 12 bars
−8.09%
Sell
AO 5, 35
Below zero and falling
−0.35
Sell
TRIX 18
Just above zero
0.005
Buy
KST 10/15/20/30, 3
Below its signal line
KST 11.73 · Signal 17.30
Sell

Volatility

Bollinger 20, 2
Lower half, %b 0.02
Up 64.76 · Mid 61.83 · Low 58.90
Neutral
Keltner 20, 10, 1.5
Inside the channel, lower half
Up 64.04 · Mid 61.33 · Low 58.62
Neutral

Volume

VWAP 345-bar
Close 7.8% above VWAP
54.74
Buy
Force Index 1
Positive, buyers in control
8.3M
Buy
ATR
1.79
3.04% of close
A/D Line
−153.9M
cumulative
OBV
−4.2M
cumulative
Volume Profile
57.45 – 59.31
POC · bull 411.7M · bear 524.5M · 44 / 56
Risk and return

Performance

Daily returns for Jan 1, 2026 – Nov 22, 2026 (YTD). About the returns · About the risk figures

1 month return

-6.67%

Change in value over the past month.

3 month return

-12.60%

Change in value over the last three months.

Max drawdown

16.77%

Largest fall from a peak to the low that followed.

Standard deviation

27.67%

How far daily returns stray from their average, annualised.

Sharpe ratio

0.52

Return above the risk-free rate per unit of volatility.

Calmar ratio

0.87

Annualised return against the maximum drawdown.

About

BMY summary

Loading summary…

Questions

BMY, answered

When was Bristol Myers Squibb founded?

Bristol Myers Squibb was formed in 1989 through the merger of Bristol-Myers Company and Squibb Corporation, although its roots go back to the early 19th century.

What recent innovations has Bristol Myers Squibb introduced?

Bristol Myers Squibb frequently announces new drugs and innovations; details can be found on their website or in press releases.

What is the mission of Bristol Myers Squibb?

Bristol Myers Squibb’s mission is to discover, develop, and deliver innovative medicines that help patients prevail over serious diseases.

In which therapeutic areas does Bristol Myers Squibb focus?

Bristol Myers Squibb focuses on areas such as oncology, immunology, cardiovascular, and fibrosis.

How does Bristol Myers Squibb ensure product quality?

BMY adheres to rigorous regulatory standards and conducts extensive testing to ensure the safety and efficacy of its products.

Does Bristol Myers Squibb pay dividends?

Yes, Bristol Myers Squibb pays dividends to its shareholders, which are usually announced quarterly.

What is Bristol Myers Squibb’s commitment to sustainability?

Bristol Myers Squibb is committed to sustainability through responsible business practices and community engagement initiatives.

What are some key products offered by Bristol Myers Squibb?

Key products include Opdivo, Yervoy, and Eliquis, which are used in cancer and cardiovascular treatment.

How can I learn more about Bristol Myers Squibb’s products?

You can visit Bristol Myers Squibb’s official website for detailed information about their products and therapeutic areas.

How does Bristol Myers Squibb support healthcare professionals?

BMY provides education, resources, and support programs to healthcare professionals to enhance patient care.

News

BMY in the news

Empower Your BMY Trading Now

Empower your trading with OHLCX. Our comprehensive platform delivers precise analysis and strategic insights for BMY, designed to improve your trading outcomes. Elevate your trading approach instantly and unlock new opportunities with our advanced system!

Maximize Results Now

Disclaimers

The information displayed on this site is sourced from third-party providers and is believed to be reliable. OHLCX has not independently verified this data and does not guarantee its accuracy. Content is for educational and informational purposes only and is not financial or investment advice.

With any investment, your capital is at risk. Past performance is no guarantee of future results. Consult your provider's terms and privacy policies where applicable.

Prices, charts and every figure derived from them are delayed by at least 15 minutes and are provided for information only; we do not guarantee their accuracy or timeliness.

Securities products are: Not FDIC insured · Not bank guaranteed · May lose value

Trademarks and logos are the property of their respective owners and do not represent endorsements of any kind.